English   Danish

2014/2015  KAN-CBIOU1004U  Innovation, Entrepreneurship and Strategy in BioBusiness

English Title
Innovation, Entrepreneurship and Strategy in BioBusiness

Course information

Language English
Course ECTS 7.5 ECTS
Type Mandatory
Level Full Degree Master
Duration One Semester
Course period Autumn
Timetable Course schedule will be posted at calendar.cbs.dk
Max. participants 12
Study board
Study Board for MSc. in Business Administration and Bioentrepreneurship
Course coordinator
  • Toke Reichstein - Department of Strategic Management and Globalization (SMG)
Several factors necessitate size restrictions for this course to max. 12 students. Students enrolling for the minor in bioentrepreneurship are selected first.

CBS students have to apply through the official CBS course enrollment and credit students must apply by filling out an application form found at www.cbs.dk.
Main academic disciplines
  • Innovation and entrepreneurship
Last updated on 17-02-2014
Learning objectives
Students learn to manage and assess different stages of the innovation process including search processes, inventions, imitations, commercialization of intangible assets and knowledge feedback loops. Furthermore, students develop skills for building projects and firms based on bio-sector opportunities enabling them effectively to translate such opportunities into sustainable businesses. Given a firm’s business and technology positions, students acquire the knowledge to assemble innovation and entrepreneurial strategies thereby assisting the organization to make decisions with regard to alternative routes in decisions given resource constraints. This also allows them to assess strategic consistency in their organizations and the consistency of the strategic choices. Students learn how to retrieve and analyze information bearing upon such choices and how to leverage on their prior training in bio-science in translating complex knowledge bodies into marketable businesses and assess their implications for the organization. Co-teaching with industry experts supports this particular pursuit of interdisciplinary competences.
Course prerequisites
Students must have completed the first year in one of the following cand.merc. programmes: FIR, FSM, ASC, AEF, IMM, IBS, MIB.
Innovation, Entrepreneurship and Stratey in BioBusiness:
Exam ECTS 7,5
Examination form Written sit-in exam
Individual or group exam Individual
Assignment type Case based assignment
Duration 4 hours
Grading scale 7-step scale
Examiner(s) Internal examiner and second internal examiner
Exam period December/January and Autumn Term
Aids allowed to bring to the exam Open book: all written and electronic aids, including internet access
Make-up exam/re-exam
Another examination form
The form of this exam may be changed for the make-up exam. If the number of registered participants for the make-up exam warrants it , the make-up exam may most appropriately be held as an oral exam (20 minutes).
Course content and structure

The course covers the following themes:

  1. Competitive dynamics of sub-industries of the bio-sector (e.g. pharmaceuticals vs. Industrial biotech)
  2. The role of institutions in the bio-sector (e.g. IPR related issues, public regulation and universities)
  3. Innovation and entrepreneurship in bio-sectors
  4. Strategy and conduct of bio-sector firms

The course examines factors shaping opportunities for innovation and entrepreneurship, and the business implications of those opportunities. The theme of strategy choices emphasize alternatives faced by emerging bio-firms and the relevant tools for strategic decision. A section of the course is focused on the strategic dimensions of patenting.

Teaching methods
Lectures, group work and simulations. Case-based teaching and use of computer-based tools for patent-based analysis of technological competition. Guest faculty from industry appears frequently in co-teaching with academic faculty.
Further Information
Course teachers: Prof. Toke Reichstein, Prof. Finn Valentin, Ass. Prof. Christoph Grimpe, PhD Stud. Karin Beukel
Expected literature

Recommended literature:

  • O'Neill, M. and Hopkins, M., 2012, A Biotech Manager's Handbook: A Practical Guide. (Biohealthcare Publishing)
  • Zenios, S., Makower, J. and Yock, P. (Editors), 2009, Biodesign: The Process of Innovating New Medical Technologies (Cambridge University Press).
  • Pisano, G.P., 2010, The evolution of science-based business: innovating how we innovate. Industrial and Corporate Change, 19, (2), 465-482.
  • Baum, A. C., Calabrese, T. & Silverman, B. S.: Don’t Go it Alone: Alliance Network Composition and Start-ups’ Performance in Canadian Biotchnology
Last updated on 17-02-2014